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Abstract: Background: Patient counselling and addressing drug-related problems are the
pharmacist’s key activities to ensure the safe and effective use of medicines. This study aimed
to describe the dispensing practice of prescribed medicines in daily community pharmacy practice
and to identify factors influencing counselling provision; Methods: An observational study was
conducted in community pharmacies in Basel, Switzerland. One master student in pharmacy
performed non-participatory observations for one day at each of the participating community
pharmacies. Patient characteristics, counselling content, additional activities, and pharmaceutical
interventions were documented on a structured checklist; Results: 556 prescription encounters (PE) in
18 participating community pharmacies were observed (269 first prescriptions; 287 refill prescriptions).
Patients were regular customers (n = 523, 94.1%) and 53.8± 23.4 years old. Counselling was provided
to 367 (66.0%) customers on 2.9 ± 3.1 themes per PE. Factors influencing counselling were dispensing
by the pharmacist, new customer, customer who did not refuse counselling, customer with a first
prescription, with a prescription resulting in a pharmaceutical intervention, and a prescription filled
by carers. During 144 PEs, 203 interventions were documented. Pharmacists proposed few additional
activities and performed no cognitive pharmaceutical service; Conclusions: Our study quantified
counselling and additional services at the dispensing of prescribed medicines and identified
influencing factors on counselling provision at the patient, prescription, and pharmacy level.
Keywords: community pharmacy practice; dispensing; counselling; pharmaceutical intervention;
pharmaceutical care; observation
1. Introduction
The Pharmaceutical Care Network Europe defined “Pharmaceutical Care” as “the pharmacist’s
contribution to the care of individuals in order to optimize medicines use and improve health
outcomes provided” [1]. As part of pharmaceutical care, patient counselling and addressing
drug-related problems (DRPs) are the pharmacist’s key activities to ensure the safe and effective
use of medicines [2,3]. Dispensing includes all activities between the reception of the patient with
a prescription and the distribution of medicines to the patient with the provision of counselling [2].
During dispensing, community pharmacists help the patient to make the best use of prescribed
medicines by providing written and oral information, responding to the patients’ needs [4]. Patients
have the opportunity to receive counselling and education about their health problems and medicines
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in several care situations, especially in community pharmacies at the time of dispensing prescribed
medicines [5]. Patient counselling about their medicines (e.g., administration, risks and benefits)
has been shown to be effective in improving medicine adherence [6,7], and in identifying DRPs [8].
In contrast, insufficient information about medicines can lead to patient non-adherence to drug therapy,
and negative health outcomes [5].
The joint International Pharmaceutical Federation and World Health Organization (FIP/WHO)
guidelines on Good Pharmacy Practice (GPP) describes the pharmacist’s function of dispensing
medicines concerning counselling as “providing advice to ensure that the patient receives and
understands sufficient written and oral information to derive maximum benefit for the treatment” [3].
Prescription dispensing at the community pharmacy is an important contact point for patient
counselling [8]. Patients regularly pick up their prescribed medicines in community pharmacies [9],
hence pharmacy staff are usually one of the last healthcare providers who interact with patients prior
to medication intake that has the possibility to counsel them [10,11]. The joint FIP/WHO GPP also
suggests minimum national standards that should be established for this function.
In Switzerland, the Swiss Association of Pharmacists published standards for pharmaceutical
counselling [12]. A service–based remuneration system for community pharmacies has been
established since 2001 [13] and some cognitive pharmaceutical services are reimbursed by the health
insurance [14,15]. The counselling provided during dispensing of prescribed medicines is remunerated
by the ‘drug check’ (fixed fee for checking each dispensed item for dosage, interactions, risk factors,
contraindications, misuse and for patient counselling, choice of optimal package size, etc.) and ‘delivery
check’ (fixed fee for managing a patient record and checking medication history) [14]. In Switzerland,
prescribers can issue refill prescriptions for up to 12 months for patients with ongoing long-term
therapies, leaving responsibility for counselling and follow-up of therapy to the pharmacist.
The literature on counselling in community pharmacies described the communication between
patient and provider about the medicines use [16,17] and compared counselling practice to
guidelines [9,18]. A Swiss study described community staff-patient interactions with a focus on
adherence [19]. This study showed that only 6.7% of all patient interactions comprised adherence
counselling, and recommended an in-depth analysis of pharmacist-patient interaction. To the authors’
knowledge, the full pattern of the daily community pharmacy practice, with all activities and
interventions a prescription triggers at the time of dispensing in a setting with remuneration for
prescription validation and counselling, have not been described yet.
For this reason, the aim of the study was to describe the observed dispensing practice of prescribed
medicines at the counter in daily community pharmacy practice, focusing on counselling, pharmaceutical
interventions and further activities, and to define factors influencing counselling provision.
2. Materials and Methods
A non-participatory observational study was conducted in community pharmacies in Basel,
Switzerland to illustrate the observed dispensing practice of prescribed medicines. The Ethics
Committee of Northwest and Central Switzerland approved the study on 25.01.2016 (EKNZ BASEC
UBE-req. 16/00011).
2.1. Data Collection
Community pharmacies in Basel, Switzerland, were randomly invited for study participation,
according to a prior study [19]. One master student in pharmacy observed pharmacy staff-customer
interactions for one day at each participating community pharmacy in a non-participatory way
during March and April 2016. The observation method was based on ad-hoc manual recording of
exchanged information during a pharmacy staff-customer interaction and subsequent transcribing
into quantitative information. After a quick briefing about the study, the pharmacy staff were neither
actively involved in data collection, nor disturbed in their usual practice. At the dispensing of
prescribed medicines, counselling content (information exchanged over the counter between customer
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and pharmacy staff), patient characteristics (e.g., age), pharmaceutical interventions (e.g., dose
adjustment) and additional activities (offered and/or performed further activity/service) were
documented on a structured checklist for each prescription encounter (PE). The non-participatory
observer stood next to a pharmacy staff member and recorded a PE from the greeting of a customer
(patient or carer) filling a prescription in the community pharmacy to closing salutations; where after,
the next customer was observed. Customers were not informed about the study to avoid any influence
on the counselling activities. Only communication in German was assessed.
The checklist was modified from a previous study [20] and enabled ad hoc coding of nine
categories and 61 predefined themes: Patient characteristics (n = 4 themes), provider (pharmacy staff
involved, n = 1), prescription (n = 7), counselling (n = 34), intervention (n = 2), physician contact
(n = 2), situation (n = 6), and additional activities (n = 5). The category counselling, including 34
counselling themes that were considered as best practice, was derived from the ‘drug check’ of the
Swiss service–based remuneration system [13], the literature [9,21,22], the requirement of the Omnibus
Budget Reconciliation Act (OBRA, 1990) [23], the recommendations for internal audits of the Swiss
Pharmacists’ Association [24], and on expert discussions with five community pharmacists. Each
theme was defined in a data dictionary to standardize the observer judgement. The checklist enabled
to distinguish between the active and passive (e.g., asking and answering questions, respectively)
involvement of the pharmacy staff and the customer during the PEs. After piloting, the checklist was
refined and cases were discussed between the observer and two experienced community pharmacists
to ensure data quality. An anonymized copy of the prescription and list of medicines from refill
prescriptions of every observed patient were additionally collected and used to test the documentation
of the observed PEs on consistency and plausibility. Observation time and characteristics of the
pharmacies and their staff were recorded separately.
The systematic documentation of the pharmaceutical interventions, performed by pharmacists,
were accomplished with aid of the Pharmacists’ Documentation of Intervention in Seamless Care
(PharmDISC) system. This classified the pharmaceutical interventions in different categories (problem,
type of problem, cause, intervention, person involved, and the outcome of the intervention) [25].
At the end of the observation day, a semi-structured interview focusing the pharmacists’ opinion
on the counselling, triggers, facilitators, and barriers was conducted with one pharmacist per pharmacy.
The results of the interviews are reported separately [26].
The main outcome measures were the number and type of themes covered in counselling,
the factors influencing counselling provision, and number, frequency, and type of pharmaceutical
interventions and additional activities.
2.2. Data Analysis
All coded data were quantified and analyzed descriptively using IBM SPSS Statistics for Windows,
Version 24 (IBM Corp., Armonk, NY, USA). For the determination of factors influencing counselling
provision, counselling theme ratios (sum of each counselling theme counselled divided by the number
of medicines dispensed on one prescription) were expressed in percentage. A mean counselling theme
ratio of 100% represented the maximum of all 34 possible counselling themes counselled for each
dispensed medicine. A single factor variance–analysis, Chi-Square, Spearman, and Mann-Whitney U
tests were used to compare variables. A p-value < 0.05 was considered statistically significant.
3. Results
Forty-nine community pharmacies were invited and 18 (37%) took part in the study. Reasons for
participation refusal were no interest (n = 7), lack of staff resources (n = 4) or time (n = 4), holidays
(n = 2), or unknown (n = 14). All pharmacies were located in the urban area of Basel. Thirteen were
independent pharmacies (72.2%), while five belonged to a pharmacy chain (27.8%). They were on
average open for 10.25 ± 1.5 h per day, and were observed during 8 ± 0.6 h (covering 78.0% of opening
hours) per day, per pharmacy. The mean number of working staff per pharmacy at the observation
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day was 5.8 ± 2.6 (1.7 ± 0.9 pharmacists, 2.8 ± 1.7 pharmacy technicians, 1.0 ± 0.3 apprentices, and
0.2 ± 0.7 pharmacists in training).
During the total observation time of 145.5 h (18 observation days), 571 PEs (mean 31.2 ± 6.4 per
pharmacy, range 22–45) were documented. Fifteen PEs had to be excluded because no medicines were
dispensed (n = 9, e.g., drug not in stock), spoken language was foreign (n = 3), ordered medicines were
picked-up (n = 1), physician-ordered medication (n = 1), or no documentation about the dispensed
medicines was available (n = 1). A total of 556 PEs (269 first PEs and 287 refill PEs) constituted the
sample for statistical analysis (each PE involved one customer).
Table 1 illustrates the characteristics of the patient, prescription, and provider. The number of
medicines on a prescription varied from 1 to 25 (mean 3.2 ± 3.2).
Table 1. Patient, prescription, and provider characteristics.
Prescription Encounter All First Refill
(n = 556) (n = 269) (n = 287)
Patient
Female n (%) 337 (60.6) 162 (60.2) 175 (61.0)
Mean age (years) ± SD 53.8 ± 23.4 45.6 ± 23.9 61.4 ± 20.2
Regular customer n (%) 523 (94.1) 242 (90.0) 281 (97.9)
Carer filled a prescription for a patient n (%) 105 (18.9) 62 (23.0) 43 (15.0)
Prescription
Ambulatory n (%) 468 (84.2) 212 (78.8) 256 (89.2)
Hospital discharge n (%) 88 (15.8) 57 (21.2) 31 (10.8)
Provider of counselling *
Pharmacist n (%) 149 (26.8) 70 (26.0) 79 (27.5)
Pharmacy technician n (%) 267 (48.0) 124 (46.1) 143 (49.8)
Apprentice n (%) 86 (15.5) 45 (16.7) 41 (14.3)
Pharmacist in training n (%) 13 (2.3) 8 (3.0) 5 (1.7)
Druggist n (%) 8 (1.4) 1 (0.4) 7 (2.4)
Combination of pharmacy staff n (%) 33 (5.9) 21 (7.8) 12 (4.2)
* Definition of the different counselling providers in Switzerland: Apprentice is a pharmacy technician in their
3-year training; pharmacist in training is a student in her/his last year of the master in pharmacy curriculum;
druggist accomplished a 4-year apprenticeship.
3.1. Counselling
The PEs lasted on average 4.5 ± 3.0 min (first 5.2 ± 3.1; refill 3.9 ± 2.7, p < 0.001), ranging from
1.0 to 23.0 min. In 106 PEs (19.1%), pharmacy staff offered counselling by asking if the patient already
knew about their medicines, or if they had any questions regarding the use of medicines (general
closed questions that were intended to verify patient need for counselling). During the 556 PEs,
counselling was provided to 367 (66.0%) customers, to 249 with first prescriptions and to 118 with
refill prescriptions (p < 0.001). Of the 367 customers, 68 (12.2%) received counselling on one theme (out
of the 34 counselling themes), 52 (9.4%) on two themes, 132 (36.0%) on three to five themes, and 115
(20.7%) on five to thirteen themes (Figure 1). Pharmacy staff did not provide any counselling in 169
refill PEs and in 20 first PEs. On average, customers were counselled on 2.9 ± 3.1 themes per PE (first
PEs 4.9 ± 3.0; refill PEs 1.0 ± 1.7, p < 0.001). Customers who refused counselling (148 PEs [26.6%]; 51
first PEs vs. 97 refill PEs, p < 0.001) were significantly more often approached for counselling at first
PEs than refill PEs (3.7 ± 2.9 theme vs. 1.7 ± 1.9, p < 0.001).
Table 2 presents the number of the counselling themes and their initiator. Pharmacy staff mainly
counselled on administration (at first PEs 465 times and at refill PEs 73 times), dose (188; 46), and use
(152; 36) and provided a label (189; 55). Of the 34 counselling themes, 8 were never addressed.
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Figure 1. Number of themes counselled by the pharmacy staff per prescription encounter (PE) during
first (n = 269) and refill PEs (n = 287).
3.1.1. Patient Involvement
The customer was actively involved in 193 (34.7%) of PEs by providing information (n = 149 PEs,
77.2%), asking questions (n = 25, 13.0%), or a combination of both (n = 19, 9.8%). During the first PEs,
the customer was more often actively involved than during refill PEs (48.7% vs. 21.6%, p < 0.001).
3.1.2. Factors Influencing Counselling Provision
Table 3 presents factors influencing counselling provision at the patient, prescription and provider
level. At patient level, new compared to regular customer received more counselling from the
pharmacy staff (11.9% vs. 5.0%, p < 0.001) (Table 3). The type of prescription also influenced the
rate of counselling. Significantly more counselling was provided with a first compared to a refill
prescription (mean theme counselling ratio 9.6% vs. 1.5%, p < 0.001), and with prescriptions requiring
a pharmaceutical intervention vs. no intervention (7.9% vs. 4.6%, p < 0.001). At the provider level,
pharmacists provided counselling on significantly more themes per PE than pharmacy technicians (3.5
vs. 2.6 themes, p < 0.05), druggists (3.5 vs. 1.9, p < 0.05), and apprentices (3.5 vs. 2.3, p < 0.05). However,
no significant difference between pharmacists and pharmacists in training (3.5 vs. 3.2, p = 0.849)
or between pharmacists and a combination of a pharmacist and another staff member (3.5 vs. 4.2,
p = 0.194) was seen.
The detection of factors influencing counselling provision allowed the illustration of counselling
patterns (Figure 2).
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Table 2. Number of counselling themes and their initiators. Bold p-values are considered as statistically significant (p < 0.05).
Counselling Themes (n = 34)
First Prescription Encounters (n = 269) Refill Prescription Encounters (n = 287) p–Value (First vs.
Refill Prescription
Encounters of
Themes Counselled
by Pharmacy Staff)
Theme
Counselled
(Pharmacy Staff)
Theme Discussed
(Pharmacy or
Customer)
Pharmacy
Staff as
Initiator
Customer
as Initiator
Initiator
Not
Known
Theme
Counselled
(Pharmacy Staff)
Theme
Discussed
(any Person)
Pharmacy
Staff as
Initiator
Customer
as Initiator
Initiator
Not
Known
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Anamnesis (total) 100 (37.2) 101 (37.5) 99 (98.0) 1 (1.0) 1 (1.0) 8 (2.8) 9 (3.1) 8 (88.9) 1 (11.1) 0 (0)
1. Medicines 34 (12.6) 35 (13.0) 33 (94.3) 1 (2.9) 1 (2.9) 3 (1.0) 4 (1.4) 3 (75.0) 1 (25.0) 0 (0) <0.001
2. Diseases 9 (3.3) 9 (3.3) 9 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0.001
3. Allergy 34 (12.6) 34 (12.6) 34 (100) 0 (0) 0 (0) 3 (1.0) 3 (1.0) 3 (100) 0 (0) 0 (0) <0.001
4. Pregnancy/lactation 8 (3.0) 8 (3.0) 8 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0.003
5. Family anamnesis 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) -
6. Lifestyle 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) -
7. Clinical parameter 15 (5.6) 15 (5.6) 15 (100) 0 (0) 0 (0) 2 (0.7) 2 (0.7) 2 (100) 0 (0) 0 (0) 0.001
8. Dose 188 (69.9) 191 (71.0) 180 (94.2) 8 (4.2) 3 (1.6) 46 (16.0) 50 (17.4) 46 (92.0) 4 (8.0) 0 (0) <0.001
Drug use (total) 152 (56.5) 153 (56.9) 143 (93.5) 9 (5.9) 1 (0.6) 36 (12.5) 38 (13.2) 36 (94.7) 2 (5.7) 0 (0)
9. Use 129 (48.0) 130 (48.3) 121 (93.1) 8 (6.2) 1 (0.8) 34 (11.8) 36 (12.5) 34 (94.4) 2 (5.6) 0 (0) <0.001
10. Duration of use (single application) 14 (5.2) 14 (5.2) 13 (92.9) 1 (7.1) 0 (0) 1 (0.3) 1 (0.3) 1 (100) 0 (0) 0 (0) <0.001
11. Instruction/training of use 9 (3.3) 9 (3.3) 9 (100) 0 (0) 0 (0) 1 (0.3) 1 (0.3) 1 (100) 0 (0) 0 (0) 0.009
Drug administration (total) 465 (172.9) 475 (176.6) 437 (92.0) 26 (5.5) 13 (2.7) 73 (25.4) 80 (27.9) 69 (86.3) 8 (10.0) 3 (3.7)
12. Frequency of administration 159 (59.1) 163 (60.6) 154 (94.5) 6 (3.7) 3 (1.8) 34 (11.8) 37 (12.9) 33 (89.2) 3 (8.1) 1 (2.7) <0.001
13. Therapy duration 90 (33.5) 91 (33.8) 85 (93.4) 4 (4.4) 2 (2.2) 13 (4.5) 13 (4.5) 11 (84.6) 1 (7.7) 1 (7.7) <0.001
14. Timing of administration 120 (44.6) 125 (46.5) 111 (88.8) 6 (4.8) 8 (6.4) 20 (7.0) 24 (8.4) 19 (79.2) 4 (16.7) 1 (4.2) <0.001
15. Modality of administration 96 (35.7) 97 (36.1) 87 (89.7) 10 (10.3) 0 (0) 6 (2.1) 6 (2.1) 6 (100) 0 (0) 0 (0) <0.001
Written information
16. Label 189 (70.3) 189 (70.3) 188 (99.5) 1 (0.5) 0 (0) 55 (19.2) 55 (19.2) 55 (100) 0 (0) 0 (0) <0.001
17. Flyer 8 (3.0) 8 (3.0) 8 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0.003
18. Schedule 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) -
19. Document 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) -
20. Indication 108 (40.1) 111 (41.3) 98 (88.3) 11 (9.9) 2 (1.8) 21 (7.3) 25 (8.7) 20 (80) 5 (20) 0 (0) <0.001
21. Effect 51 (19.0) 52 (19.3) 49 (94.2) 3 (5.8) 0 (0) 7 (2.4) 7 (2.4) 6 (85.7) 1 (14.3) 0 (0) <0.001
22. Mechanism of action 1 (0.4) 1 (0.4) 1 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0.48
23. Benefit/purpose of therapy 3 (1.1) 4 (1.5) 3 (75) 1 (25.0) 0 (0) 8 (2.8) 9 (3.1) 7 (77.8) 2 (22.2) 0 (0) 0.226
24. Adverse effect 18 (6.7) 18 ( 6.7) 16 (88.9) 1 (5.6) 1 (5.6) 6 (2.1) 7 (2.4) 6 (85.7) 1 (14.3) 0 (0) 0.011
25. Red flag 3 (1.1) 3 (1.1) 3 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0.11
26. Drug-drug interaction 17 (6.3) 18 (6.7) 13 (72.2) 5 (27.8) 0 (0) 4 (1.4) 4 (1.4) 4 (100) 0 (0) 0 (0) 0.003
27. Contraindication 1 (0.4) 1 (0.4) 1 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0.48
Appropriate action in case of:
28. Missed dose 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) -
29. Underdose 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) -
30. Overdose 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) -
31. Storage 5 (1.9) 5 (1.9) 5 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0.025
32. Information transfer 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) -
33. Adherence 12 (4.5) 12 (4.5) 12 (100) 0 (0) 0 (0) 23 (8.0) 23 (8.0) 22 (95.7) 1 (4.3) 0 (0) 0.116
34. Self-/monitoring 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (0.3) 1 (0.3) 1 (100) 0 (0) 0 (0) -
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Table 3. Factors influencing counselling provision. Bold p-values are statistically significant (p < 0.05).
Variable 1
Mean Ratio of PEs with at Least
One Counselling Theme [%]
Average± SD
Variable 2
Mean Counselling
Theme Ratio [%]
Average± SD
p-value
Patient
Regular customer [n = 523] 5.0 ± 6.1 New customer [n = 33] 11.9 ± 6.3 <0.001
Female patient [n = 337] 5.2 ± 6.1 Male patient [n = 219] 5.8 ± 6.5 0.436
Counselling not refused [n = 408] 6.2 ± 6.7 Counselling refused [n = 148] 3.5 ± 4.6 0.001
Prescription filled by the patient [n = 451] 5.1 ± 6.2 Prescription filled by the carer [n = 105] 6.7 ± 6.7 0.026
Prescription
First prescription [n = 269] 9.6 ± 6.2 Refill prescription [n = 287] 1.5 ± 3.1 <0.001
Ambulatory prescription [n = 468] 5.3 ± 6.2 Discharge prescription [n = 83] 6.7 ± 6.7 0.088
Prescription with interventions [n = 144] 7.9 ± 6.6 No intervention [n = 412] 4.6 ± 6.0 <0.001
Hand written prescription [n = 247] 7.5 ± 6.7 Printed prescription [n = 117] 7.0 ± 6.3 0.599
All medicines directly dispensed [n = 495] 5.7 ± 6.4 Some medicines picked up later [n = 61] 3.2 ± 4.6 0.004
>1 medicine dispensed [n = 290] 5.7 ± 5.9 1 medicine dispensed [n = 266] 5.2 ± 6.7 0.027
>1 medicine on prescription [n = 353] 5.0 ± 5.8 1 medicine on prescription [n = 182] 6.5 ± 7.2 0.129
Provider of counselling
Pharmacist [n = 149] 6.3 ± 6.6 Pharmacy technician [n = 267] 5.0 ± 6.1 0.018
Druggist [n = 8] 2.4 ± 6.8 0.019
Apprentice [n = 86] 4.6 ± 5.4 0.045
Combination of a pharmacist and a other
staff member [n = 33] 7.6 ± 7.8 0.476
Pharmacist in training [n = 13] 6.7 ± 5.7 0.651
Situation
Stress factor by waiting customers [n = 89] 6.5 ± 6.6 No waiting customer [n = 467] 5.3 ± 6.2 0.059
Silent environment [n = 500] 5.4 ± 6.4 Loud environment [n = 56] 5.6 ± 5.9 0.582
No disruption during counselling [n = 550] 5.5 ± 6.3 Disruption during counselling [n = 6] 3.9 ± 4.8 0.610
No communication problem [n = 548] 5.4 ± 6.3 Communication problem [n = 8] 6.9 ± 6.5 0.525
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3.2. Pharmaceutical Interventions
During all 18 observation days, 203 pharmaceutical interventions were documented at 144 PEs
(intervention rate 25.9%). Interventions occurred significantly more at first PEs (n = 103) vs. refill
PEs (n = 41; p < 0.001), with an average per prescription of 1.4 ± 0.7 (range 1–4). Pharmacists’
intervention mainly included drug substitution (n = 89, 43.8%), clarification of information (n = 64,
31.5%), and adjustment of the package size/quantity (n = 39, 19.2%). Table 4 represents the most
frequent pharmaceutical interventions. The cause was technical for 180 pharmaceutical interventions
(88.7%) and clinical for 23 pharmaceutical interventions (11.3%). Active interaction with the prescriber
was necessary in 11 (5.4%) pharmaceutical interventions, whereas the involvement of the patient was
observed in 127 (62.6%) pharmaceutical interventions and neither the prescriber nor the patient was
involved in 65 (32.0%) pharmaceutical interventions.
Table 4. The most frequently observed pharmaceutical interventions, their cause and type of problem
(documented with the PharmDISC system).
Intervention Cause of Intervention Type of Problem n (%)
Total interventions 203 (100.0)
Technical 180 (88.7)
Clarification/addition of information Incomplete/unclear prescription Manifest, reactive 55 (27.1)
Substitution (generic) Financial burden Manifest, reactive 49 (24.1)
Substitution Prescribed drug not available Manifest, reactive 31 (15.3)
Adjustment of package size/quantity Financial burden Manifest, reactive 18 (8.9)
Adjustment of package size/quantity Financial burden Manifest, reactive 9 (4.4)
Clinical 23 (11.3)
Adjustment of package size/quantity Concerns about the treatment Manifest, reactive 3 (1.5)
Substitution No concordance with guidelines,only suboptimal therapy possible Potential, preventive 2 (1)
Substitution Concerns about the treatment Manifest, reactive 2 (1)
Therapy stopped/no delivery Drug-drug interaction Potential, preventive 2 (1)
In-depth counselling of patient Drug-drug interaction Potential, preventive 2 (1)
The number of pharmaceutical interventions per PE increased with the frequency of counselled
themes per PE (correlation r = 0.270, p < 0.001) and with the frequency of dispensed medicines per PE
(r = 0.236, p < 0.001). The number of pharmaceutical interventions per PE did not increase with the age
of the patients (r = −0.018, p = 0.687) or the work experience of the pharmacy staff (r = 0.032, p = 0.470).
3.3. Additional Activities
Of all PEs, 10 PEs resulted in a phone call with the physician, five in a referral to the physician,
one PE in a consultation in a separate room, and one PE in a refusal of dispensing. The pharmacists
reconstituted seven suspensions, and offered three follow-ups. Non-pharmacological counselling
(e.g., balanced nutrition) was provided at 11 PEs (11 first, 0 refill, p < 0.001).
4. Discussion
This observation study allowed depicting the dispensing practice of prescribed medicines at the
counter of Swiss community pharmacies and analysing factors influencing counselling provision.
4.1. Counselling
Counselling was provided to 66.0% of the customers receiving prescribed medicines, which is
slightly more than in a previous observation study (57.3%) performed in Switzerland in 2010 [19].
A review of worldwide counselling practices on prescribed medicines reported counselling rates from
12% to 100%, when observational methods were used [17]. In this study, the customers were counselled
on up to 13 out of the 34 predefined counselling themes per PE. However, in real daily practice,
34 different themes cannot be counselled at one PE, as this would overload the patient. Staff members
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have to decide on priorities during the interaction with the patient. With refill prescriptions, additional
themes can be counselled at following visits. Written information in the form of an individualized
label to reinforce verbal communication was provided in 43% of the PEs.
A quarter of customers refused counselling and one-third of the customers did not receive any
counselling. The study design did not take into account the long-term relationship between the
pharmacy staff and the patient as a regular customer, with pre-existing counselling provided at a
prior PE, which could lead to PEs without observed counselling. This is in line with what was
observed previously: New customers received more counselling than regular customers. Nevertheless,
this study depicted how the patient received the counselling at the counter. The findings revealed
that pharmacists were involved in direct patient contact at the counter in only a quarter of all PEs.
Pharmacists’ activities, such as drug interaction-check and investigating medication history, have often
been done in the back office, and are neither visible, nor communicated to the customer. If pharmacy
staff were more transparent and better communicated their activities to the customer during dispensing,
this could improve trust and collaboration.
The themes of counselling were more product-centered (e.g., dose, administration) than
patient-centered (e.g., adherence, therapy benefit), similar to the findings of other studies [17,19,27].
Indeed, the counselling patterns of Figure 2 illustrate the gaps in patient-centered counselling.
Especially for patients refilling prescribed medicines, low counselling ratios were observed. Not
addressing the patient-centered counselling themes at refill might be interpreted as a missed
opportunity to improve patients’ adherence to their drug therapy. It is known that patients often stop
taking their newly prescribed medicines in the first months of therapy (medication non-persistence),
because of concerns (e.g., adverse effect) and lack of perceived need (e.g., poor understanding of
medicines/disease) [28,29]. To address adherence issues, remunerated cognitive pharmaceutical
services (e.g., ‘Polymedication check’, ‘Adherence fee’) were introduced in Switzerland since 2010 [14],
but during the observation, none of these services were performed.
Pharmacy staff–customer interactions have been observed before and the findings have been
similar internationally. Although countries and guidelines adopted pharmaceutical care as one
of the key roles for community pharmacist, they are reported to be delivered only in a limited
way [21,30–33]. Counselling rates are usually rather low, and the content is mostly about the
medication (product-centered) [16,17,19]. Patient-centered issues are seldom discussed in a pharmacy
staff-customer interaction and pharmaceutical care services are not provided to their full potential [32].
Our study confirms these results although in Switzerland, counselling about prescribed medicines and
certain pharmaceutical care services are remunerated by the health insurance. To our knowledge, this
is the first study observing the daily practice of dispensing prescribed medicines at the community
pharmacy under these conditions. Another possible barrier is the non-conformity of roles and
expectations between pharmacy staff and customers [34]. Educational interventions have shown
success in improving counselling by pharmacists [35].
4.1.1. Patient Involvement
This observational study showed that the pharmacy staff were the main initiators of discussion,
confirming the findings of another observational Dutch study, which videotaped their encounters [9].
A systematic review revealed a mainly passive role of the patient in conversations with healthcare
providers [36], even though guidelines encourage interactive communication [5]. This is in line with
this observational study; customers asked only a few questions, although these questions might give
the pharmacy staff the opportunity to tailor information on patients’ needs [4]. Lack of privacy at
the counter [37], lack of interest in pharmacy counselling [38–40], and patients’ underestimation of
pharmacists’ role in healthcare are possible reasons for patients’ barriers in asking questions [27,34,41].
Nevertheless, the patients’ initiative would be important, knowing that the outcome of a dialogue
depends on the person who initiates the discussion [42]. Indeed, in patient-centered care, the patient
always comes first, and their needs should drive the PE [43]. Therefore, the patient should be
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encouraged in PEs to be more active in the discussion. Furthermore, the findings revealed that
pharmacy staff sometimes offered counselling only by asking general closed questions (e.g., do you
know this medicine already?), limiting the counselling provision and the patient involvement, and
consequently not taking into account the patients’ needs. It has been shown that the counselling
provided to the patients does not fulfil their information needs [44]. A study exploring advice-giving
behavior in British community pharmacies reported that the counselling was mostly based on product
use, and that the customers wished information about the drug’s effectiveness, while the pharmacists
provided information on drug safety. The authors proposed a protocol to guide pharmacy staff,
including the customers’ perspective [27]. To meet patient needs, the pharmacists should better listen
to the patients’ problems and provide individualized counselling [45].
4.1.2. Factors Influencing Counselling Provision
Counselling was not equally provided, suggesting that pharmacy staff use different levels of
counselling at PEs. If extended counselling at each first and refill PE is not possible in daily practice,
pharmacy staff should target counselling for specific situations. However, it is important to notice that
each PE offers to the pharmacist an opportunity to interact with the patient and hence to detect DRPs
and patients’ concerns. The study findings highlight some factors influencing counselling provision at
the patient, prescription and provider level. These indicators could help in prioritizing prescriptions
needing in-depth counselling.
Patient level
• New customers were more likely to receive counselling from the pharmacy staff than regular
customers. The counselling patterns revealed that the pharmacy staff performed more likely an
anamnesis (medicine, diseases, and allergy) with the new customers, while the counselling
patterns of the other factors influencing counselling provision were comparable (Figure 2).
Similarly, to a review [17], the pharmacy staff mainly counselled on administration, dose and use.
• Customers who did not refuse counselling received more counselling. Refusing counselling did
not mean that the patient did not receive any counselling, but such refusal is known to be an
important barrier for the provision of counselling [19]. Lack of patient interest is a common
phenomenon during counselling in community pharmacy [38,39], up to 41–63% patients decline
a counselling offer [33,40], leading to low counselling ratios [40].
• Carers who filled a prescription for a patient received more information on the prescribed
medicines than the patients themselves. Possibly, the carer was not present at the consultation
with the prescriber and did not receive information on the patient’s drug therapy.
Prescription level
• Customers with a first prescription received more counselling than customers with a refill
prescription. In a first PE, it is important to ensure that the patient receives the knowledge
for using their medicines correctly [19]. Appropriate drug use is ensured by counselling on
therapy duration, dosage, and optimal timing of drug intake [46]. At refill PE, pharmacists could
suppose that patients with chronic medication were already informed about their use [47]. They
could also be regular customers needing less clarification. Previous studies showed that pharmacy
staff classified the communication with patients to be more difficult during refill PE than during
the first PE [48,49]. It has been shown that patients’ expectations towards counselling are different
in first and refill PEs. More interest by patients during a first PE may facilitate more extensive
counselling [40]. This is in line with the study findings: During the first PEs, patients showed
more interest in counselling than during refill PEs, as two thirds of the counselling refusals were
observed during refill PEs.
• Prescriptions that resulted in a pharmaceutical intervention required more counselling than
prescriptions without any intervention, because interventions imply to inform the patient about
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the DRP, and to involve him/her in solving it. Additionally, these prescriptions must involve the
pharmacist, who is known to give more counselling than other pharmacy staff member.
Provider level
• Pharmacists provided more counselling to customers than other pharmacy staff members. Other
studies reported this factor as well [19,47,50]. A reason could be that pharmacists have a larger
knowledge about drug therapy. Counselling should be driven by the patient and the prescription,
not by the randomly allocated pharmacy staff member.
Counselling quality can be improved by developing counselling skills through education
(e.g., role-play with standardized patients [51]), patient-centered communication (concordance of
provided care with patients’ preferences and needs) [52,53], the implementation of established guidelines
on Good Pharmacy Practice [3], and continuing evaluation with feedback (e.g., mystery shopper).
4.2. Pharmaceutical Interventions
The study findings confirm that the community pharmacists were effective in detecting,
preventing, and solving DRPs [4,54]. By intervening during dispensing, pharmacists contributed
to the safe, appropriate, and cost-effective use of drugs. Individual judgement and professional
knowledge of the pharmacists and collaboration with the patient, carer, or prescriber was needed
to respond satisfactorily to the patient needs. The rate of pharmaceutical interventions (25.9%) was
comparable to a German study describing DRPs at time of dispensing prescribed medicines, which
reported an intervention rate of 18.0% [54].
4.3. Additional Activities
Pharmacy staff proposed only a few additional activities during PE, missing the opportunity to
offer additional care and ensure continuity of care and optimize patient therapy and health outcomes.
Notably, each refill prescription is an opportunity for the pharmacists to offer follow-up and further
cognitive pharmaceutical services. Although such services are remunerated in Switzerland [14], none
of the pharmacists proposed a medication review (e.g., ‘polymedication check’) or an adherence
aid (e.g., ‘adherence fee’) to the customer during the observation time of 18 days. However, they
often performed ‘generic substitution’ for newly prescribed medicines. This limited practice of
pharmaceutical care in community pharmacies confirms the results of previous findings [33,50,55] and
indicates that the implementation of these cognitive pharmaceutical services is still challenging.
4.4. Strengths and Limitations
The approach of the study to describe the dispensing practice of prescribed medicines at the
counter was a non-participant observation, which is a useful way to study the quality of services
and consistency of care [56]. The full pattern of the real-life situation, with all of the activities and
interventions triggered by a prescription at the time of dispensing could be described, which forms a
basis to improve these processes. In general, observations allow the description of customers’ behavior
and practice in real daily life [57], avoiding consequently the biases of self-report methods [46].
The observation method used in this study was based on ad-hoc note-taking of exchanged information
and subsequent transcribing into quantitative information. This demonstrated that observation is
a feasible method to provide valuable insight into pharmacies’ activities. The documentation of
the observed PEs has been tested for consistency and plausibility. The data was collected in 18
randomly selected pharmacies; however, the study was restricted to one region in Switzerland.
The principal limitation was the presence of an observer, which could positively influence the
counselling performance of the pharmacy staff by triggering them to be more aware of their way of
approaching customers (the Hawthorne effect) [58]. To minimize this effect, the observer became
accustomed to the pharmacy staff prior data collection to make them feel comfortable. Moreover,
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the observation lasted a whole working day, which allowed observation of normal practice over time.
Simulated client methods, such as mystery shopping, could minimize observation bias, but present
limitations of their own. The extracted information corresponds to a small part (snapshot) of healthcare
practice only, and is therefore hard to generalize to other healthcare situations [59]. The observations
were not recorded and not reviewed by a second investigator, which might have limited the reliability
of the results.
5. Conclusions
The observation of the dispensing practice of prescribed medicines at community pharmacies
resulted in a picture about processes and activities triggered by a customer with a prescription in
an everyday practice setting. We identified factors influencing counselling provision at the patient,
prescription and provider level: Dispensing by the pharmacist, the customer with a first prescription,
customer with a prescription requiring a pharmaceutical intervention, carer filling the prescription
for a patient, new customer, and customer not refusing counselling. Counselling was not evenly
provided, indicating that pharmacy staff counsel different customers to different degrees. The themes
of counselling were more product-centered than patient-centered. With a more transparent practice
and patient-centered counselling, pharmacy staff could improve to address the patients’ needs on
medicines information. Pharmacists intervened frequently, however, only a few additional activities
and no further services (e.g., adherence support) were offered. Education of pharmacy staff should
focus more on patient-centered counselling and the customers should be informed about the role of
the pharmacist. Further research will analyze the pharmacists’ opinions gathered within this project.
Interventional studies could be used to investigate factors for enhancing pharmacy staff-customer
interactions overcoming known barriers.
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